Whitehawk Therapeutics (WHWK) Operating Income (QoQ) (2010 - 2026)

Whitehawk Therapeutics (WHWK) Operating Income (QoQ) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Whitehawk Therapeutics 34.18 Mn 34.18 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 5.48%
Dec 31, 2025 -27.33%
Sep 30, 2025 64.30%
Jun 30, 2025 -259.76%
Mar 31, 2025 19.69%
Dec 31, 2024 -41.27%
Sep 30, 2024 13.93%
Jun 30, 2024 20.13%
Mar 31, 2024 -10.15%
Dec 31, 2023 0.76%
Sep 30, 2023 8.68%
Jun 30, 2023 -16.17%
Mar 31, 2023 -8.74%
Dec 31, 2022 -2.90%
Sep 30, 2022 18.10%
Jun 30, 2022 -32.91%
Mar 31, 2022 13.36%
Dec 31, 2021 81.74%
Sep 30, 2021 -2,153.19%
Jun 30, 2021 5.19%